Table 3.
Particle sizes of the loteprednol etabonate ointment formulations via PLM (n=3)
| Formulations | D10 (µm) | D50 (µm) | D90 (µm) | D99 (µm) |
|---|---|---|---|---|
| SRTOWP19 | 1.43 ± 0.00 | 3.10 ± 0.21 | 9.15 ± 1.34 | 18.54 ± 3.51 |
| HMICOWP19 | 1.79 ± 0.00 | 3.57 ± 0.00 | 9.88 ± 1.09 | 22.8 ± 2.89 |
| HMRTOWP19 | 1.74 ± 0.08 | 3.57 ± 0.36 | 9.07 ± 0.58 | 15.58 ± 1.44 |
| SRTNWP19 | 1.79 ± 0.00 | 4.17 ± 0.21 | 10.67 ± 1.21 | 20.98 ± 1.12 |
| HMICNWP19 | 1.55 ± 0.21 | 3.21 ± 0.00 | 9.88 ± 0.55 | 20.05 ± 1.91 |
| HMRTNWP19 | 1.79 ± 0.00 | 4.41 ± 0.41 | 11.36 ± 0.12 | 21.49 ± 1.61 |
| API 19 µm | 1.79 ± 0.00 | 5.48 ± 1.44 | 17.43 ± 2.26 | 40.07 ± 4.17 |